ah 6809 has been researched along with palmitic acid in 1 studies
| Studies (ah 6809) | Trials (ah 6809) | Recent Studies (post-2010) (ah 6809) | Studies (palmitic acid) | Trials (palmitic acid) | Recent Studies (post-2010) (palmitic acid) |
|---|---|---|---|---|---|
| 163 | 1 | 49 | 6,794 | 159 | 2,458 |
| Protein | Taxonomy | ah 6809 (IC50) | palmitic acid (IC50) |
|---|---|---|---|
| Toll-like receptor 2 | Homo sapiens (human) | 5 | |
| Fatty acid-binding protein, intestinal | Homo sapiens (human) | 1.7 | |
| Fatty acid-binding protein, adipocyte | Homo sapiens (human) | 0.93 | |
| Tyrosine-protein phosphatase non-receptor type 1 | Homo sapiens (human) | 8.8 | |
| Fatty acid-binding protein 5 | Homo sapiens (human) | 1.2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhatnagar, A; Hellmann, J; Rane, M; Spite, M; Tang, Y; Zhang, MJ | 1 |
1 other study(ies) available for ah 6809 and palmitic acid
| Article | Year |
|---|---|
Increased saturated fatty acids in obesity alter resolution of inflammation in part by stimulating prostaglandin production.
Topics: Animals; Apoptosis; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dinoprostone; Fatty Acids; Humans; Inflammation; Macrophages; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neutrophils; Obesity; Palmitic Acid; Peritonitis; Phagocytosis; Prostaglandin D2; Receptors, Prostaglandin; Receptors, Prostaglandin E, EP2 Subtype; Xanthones | 2013 |